Our Regulatory folks just returned from a conference and a presentation by Robert Campbell. The take home message was that the JC will be be changing their attitute towards titration range orders and will be looking instead to the compliance to the institution's own policy. I have attached the policy verbiage from the presentation, has anyone else tackled this one recently? I'd love to hear of any successes with the JC and titration range orders.
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to email@example.com.